课题基金 / 基金详情

项目摘要

项目成果

Bimal K Banik的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Latino/Hispanic population is the largest minority in the US and the highest concentration of Latinos is along the US-Mexico Border. To address the specific needs of this population in cancer research and education, a partnership between The University of Texas-Pan American and the Cancer Center at The University of Texas Health Science Center at San Antonio is proposed. The goals of this application are to develop research and training partnerships to increase the cancer research base on the US-Mexico border. The projects proposed will not only develop translational research in basic science but also address cancer related health disparities in the Hispanic border population. The specific goals of the application are: 1. to develop and foster cancer research at UTPA; 2. to foster research dedicated towards reducing the cancer burden of the Hispanic population with emphasis on the US-Mexico border, and 3. to increase the number of cancer researchers coming from South Texas. To accomplish these goals, two pilot projects and a training program are proposed. The first pilot project is a basic science project which will take advantage of the expertise at UTPA to synthesize polycyclic aromatic compounds and expertise at UTHSCSA to test these compounds as anticancer agents. The second pilot project is directed toward understanding the attitudes and decision making processes in genetic testing for increased breast cancer risk. The third project is a summer undergraduate program for UTPA students to work in laboratories and to learn about cancer biology with the goal of increasing the number of students from communities in South Texas interested in cancer research. This multidimensional approach will heighten cancer research and education in the Hispanic/Latino population along the Texas border.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Novel 6,12-disubstituted chrysene as potent anticancer agent: synthesis, in vitro and in vivo study.
新型 6,12-二取代屈作为有效的抗癌剂:合成、体外和体内研究。
DOI: 10.1016/j.ejmech.2010.07.033
发表时间: 2010
期刊: European journal of medicinal chemistry
影响因子: 6.7
作者: [Banik,BimalK, Becker,FrederickF]
通讯作者: Becker,FrederickF
A microwave-assisted bismuth nitrate-catalyzed unique route toward 1,4-dihydropyridines.
微波辅助的硝酸二核培养基沿1,4-二氢吡啶的独特途径。
DOI: 10.3390/molecules17032643
发表时间: 2012-03-05
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者: [Bandyopadhyay D, Maldonado S, Banik BK]
通讯作者: Banik BK
DOI: 10.1007/s10903-013-9828-2
发表时间: 2014-08
期刊: JOURNAL OF IMMIGRANT AND MINORITY HEALTH
影响因子: 1.9
作者: [Su, Dejun, Pratt, William, Stimpson, Jim P., Wong, Rebeca, Pagan, Jose A.]
通讯作者: Pagan, Jose A.
Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
作为抗癌剂的新型芘基衍生物的设计、合成和生物学评价。
DOI: 10.1016/j.ejmech.2014.09.072
发表时间: 2015
期刊: European journal of medicinal chemistry
影响因子: 6.7
作者: [Bandyopadhyay,Debasish, Sanchez,JorgeL, Guerrero,AdrianM, Chang,Fang-Mei, Granados,JoseC, Short,JohnD, Banik,BimalK]
通讯作者: Banik,BimalK
UTPA - Cancer Center at UTHSCSA Border Partnership (1 of 2)
UTPA - Cancer Center at UTHSCSA Border Partnership (2 of 2)
UTPA - Cancer Center at UTHSCSA Border Partnership (1 of 2)
UTPA - Cancer Center at UTHSCSA Border Partnership (2 of 2)
海外基金